- Home
- / Karolinska Development
Karolinska Development
Stock Price
KR1.2
2024-10-29
Market Capitalization
KR325.4 M
2024-10-29
Revenue
KR1.7 M
FY, 2025
Karolinska Development Summary
Company Summary
- Overview
- Karolinska Development is specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors.
- Type
- Public
- Status
- Active
- Founded
- 2003
- HQ
- Solna, SE | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Solna, Stockholms län HQ
Sweden
Tomtebodavägen 23a
Karolinska Development Financials
Summary Financials
- Revenue (FY, 2025)
- kr1.7M
- Gross profit (FY, 2025)
- kr1.7M
- Net income (FY, 2025)
- (kr193.9M)
- Cash (FY, 2025)
- kr23.9M
- EBIT (FY, 2025)
- (kr130.3M)
- Enterprise value
- $302.6M